Hematology-Oncology Associates of the Quad-Cities, PC
Colorectal Cancer Trials
NSABP R-04: Treatment With 5fu continuous infusion, or 5FU infusion + xeloda, or xeloda alone, or XELOX Combined With Radiation Therapy For Patients With Rectal Cancer
E5202: A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
E5202: A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
